Your valid home address is used to determine which NY State Senator Represents you.

Apt/Suite/Floor (Optional)

City *

State *

Postal Code *

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Send me alerts for this bill. I can unsubscribe at any time. Learn more.

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

S9100 - Details

S9100 - Summary

Enacts the drug take back act requiring certain manufacturers to operate a drug take back program to accept and dispose of covered drugs; provides that for any city with a population of one hundred twenty-five thousand or more as of the last decennial census, the commissioner of health shall establish by regulation a distribution plan that ensures that on-site collection receptacle or dropbox placement shall be reasonably accessible to all residents.

S9100 - Sponsor Memo

BILL NUMBER: S9100
TITLE OF BILL :
An act to amend the public health law, in relation to enacting the
drug take back act
PURPOSE :
To establish a statewide drug take back program for the safe disposal
of drugs.
SUMMARY OF PROVISIONS :
Section one provides the bill shall be known as the Drug Take Back
Act.
Section two adds a new Article 2-b to the Public Health Law which
provides for the safe disposal of drugs statewide. Under this Act,
manufacturers of covered drugs must either submit, individually or
jointly, a drug take back program for approval by the Department of
Health, or enter into an agreement with the Department to operate a
drug take back program on its behalf. Under such program,
manufacturers are responsible for all administrative and operational
fees associated with their take back program, including the cost of
collecting, transporting and disposing of covered drugs from

pharmacies and other authorized collectors and the recycling or
disposal, or both, of packing collected with the covered drug. This
Act further requires chain pharmacies and mail-order pharmacies to
provide for the collection of covered drugs by providing consumers
with on-site collection, prepaid mail-back envelopes or other Drug
Enforcement Agency (DEA) approved methods.
Section three amends Public Health Law § 3343-b to make conforming
changes.
Section four provides the effective date.
JUSTIFICATION :
New York, like the rest of the nation, continues to struggle with the
opioid addiction crisis. Despite our best effects to stem the tide of
opioid related deaths by, among other things, increasing access to
Naloxone, enacting I-STOP to prevent doctor shopping, limiting initial
prescriptions to 7 days, and changing the Insurance Law to make
treatment more accessible, the number of deaths continue to rise. It
is well known the first supply of opioids is often leftover medication
a family member or friend received and did not use. To cut off this
supply, we must make the take back and disposal of these drugs more
prominent and accessible.
In addition to getting excess drugs out of medicine cabinets where
they are ripe for abuse, a statewide drug take back program will help
ensure these and other drugs are not improperly disposed by flushing
or other means that results in harm to our water bodies and impacts
aquatic life.
Last year New York made a historic investment in improving and
protecting our water, keeping drugs out of our water supplies is
another important and necessary step.
While law enforcement agencies have drop-off points and elected
officials hold drug take back days that help properly dispose of many
drugs, more must be done. Chapter 79 of the Laws of 2015, allowed
pharmacies and other DEA authorized collectors to collect unused
controlled substances in New York. While this was an important step in
making it easier for people to take back their unused medications,
voluntarily participation remains low. The Department of Environmental
Conservation recently announced a pilot program that provides take
back receptacles at participating pharmacies, hospitals and long-term
care facilities, but again this program is voluntary and limited in
scope. Meanwhile, a recent effort to require chain pharmacies
statewide, and mail-order pharmacies, to participate in drug take back
was vetoed by the Governor.
Product Stewardship is the concept that whoever manufactures,
produces, or sells a product take responsibility for minimizing the
product's environmental impact throughout all stages of the products'
life cycle, including its disposal or destruction. Over the years, New
York has developed product stewardship programs for products such as
electronic waste, rechargeable batteries, and mercury thermostats.
Drug stewardship programs are however, still largely in their infancy.
In 2012, Alameda County, CA became the first government to pass
legislation requiring pharmaceutical manufacturers to design, fund and
operate a program to safely collect and dispose unwanted drugs.
Alameda's program withstood court scrutiny, with the Ninth Circuit
Court of Appeals finding its provisions did not violate the Dormant
Commerce Clause. On May 26, 2015, the Supreme Court of the United
States denied certiorari.
The Alameda case paved the way, with now nine counties in California
and more recently the state of Massachusetts and several counties in.
New York adopting similar programs. However, many of the existing drug
stewardship programs continue to rely solely on voluntary retail
participation, which has already proven to be low in New York. Retail
participation is critical in reaching consumers and getting the most
benefit from a take back program. Just as individuals can return
tires, car batteries and motor oil to the businesses they purchased
them from, New Yorkers should be able dispose of drugs, or obtain a
prepaid mail-back envelope, through a pharmacy. Thus, this legislation
will provide for unified, statewide drug take back, to be paid for by
manufacturers, and require participation of chain and mail-order
pharmacies. Manufacturers will be responsible for all costs from
public education and awareness to collection, transport and
destruction, and pharmacies will provide methods for convenient
drop-off and collection.
LEGISLATIVE HISTORY :
New bill.
FISCAL IMPLICATIONS :
None.
EFFECTIVE DATE :
This act shall take effect on the one hundred eightieth day after it
shall have become a law. Effective immediately, the addition,
amendment and/or repeal of any rule or regulation necessary for the
implementation of this act on its effective date are authorized to be
made and completed on or before such effective date.

S T A T E O F N E W Y O R K
________________________________________________________________________
9100
I N S E N A T E
June 16, 2018
___________
Introduced by Sens. HANNON, O'MARA -- read twice and ordered printed,
and when printed to be committed to the Committee on Rules
AN ACT to amend the public health law, in relation to enacting the drug
take back act
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. This act shall be known and may be cited as the "drug take
back act."
S 2. The public health law is amended by adding a new article 2-B to
read as follows:
ARTICLE 2-B
DRUG TAKE BACK
SECTION 290. DEFINITIONS.
291. DRUG TAKE BACK.
292. COLLECTION.
293. VIOLATIONS.
294. JURISDICTION.
S 290. DEFINITIONS. AS USED IN THIS ARTICLE, UNLESS THE CONTEXT CLEAR-
LY REQUIRES OTHERWISE:
1. "AUTHORIZED COLLECTOR" MEANS: (A) A PERSON, COMPANY, CORPORATION OR
OTHER ENTITY THAT IS REGISTERED WITH THE UNITED STATES DRUG ENFORCEMENT
ADMINISTRATION TO COLLECT CONTROLLED SUBSTANCES FOR THE PURPOSES OF SAFE
DISPOSAL AND DESTRUCTION; (B) A LAW ENFORCEMENT AGENCY; OR (C) A PERSON,
COMPANY, CORPORATION OR OTHER ENTITY AUTHORIZED BY THE DEPARTMENT TO
PROVIDE ALTERNATIVE COLLECTION METHODS FOR COVERED DRUGS THAT ARE NOT
CONTROLLED SUBSTANCES.
2. "COVERED DRUG" MEANS ANY SUBSTANCE RECOGNIZED AS A DRUG UNDER 21
USC S 321(G)(1), AS AMENDED, AND ANY REGULATIONS PROMULGATED THEREUNDER
THAT IS SOLD, OFFERED FOR SALE OR DISPENSED IN THE STATE, WHETHER
DIRECTLY OR THROUGH A WHOLESALER, IN ANY FORM INCLUDING PRESCRIPTION AND
NONPRESCRIPTION DRUGS, DRUGS IN MEDICAL DEVICES AND COMBINATION
PRODUCTS, BRAND AND GENERIC DRUGS AND DRUGS FOR VETERINARY USE; PROVIDED
HOWEVER, COVERED DRUG SHALL NOT INCLUDE: (A) VITAMINS OR SUPPLEMENTS;
(B) HERBAL-BASED REMEDIES AND HOMEOPATHIC DRUGS, PRODUCTS OR REMEDIES;
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.

LBD14168-16-8
S. 9100 2
(C) COSMETICS, SOAP (WITH OR WITHOUT GERMICIDAL AGENTS), LAUNDRY DETER-
GENT, BLEACH, HOUSEHOLD CLEANING PRODUCTS, SHAMPOOS, SUNSCREENS, TOOTH-
PASTE, LIP BALM, ANTIPERSPIRANTS OR OTHER PERSONAL CARE PRODUCTS THAT
ARE REGULATED AS BOTH COSMETICS AND NONPRESCRIPTION DRUGS UNDER THE
FEDERAL FOOD, DRUG, AND COSMETIC ACT; (D) PET PESTICIDE PRODUCTS
CONTAINED IN PET COLLARS, POWDERS, SHAMPOOS, TOPICAL APPLICATIONS, OR
OTHER FORMS; (E) DRUGS THAT ARE BIOLOGICAL PRODUCTS AS DEFINED IN SUBDI-
VISION TWENTY-SEVEN OF SECTION SIXTY-EIGHT HUNDRED TWO OF THE EDUCATION
LAW IF THE MANUFACTURER ALREADY PROVIDES A TAKE BACK PROGRAM; (F) DRUGS
FOR WHICH A MANUFACTURER PROVIDES A TAKE BACK PROGRAM AS PART OF A
FEDERAL FOOD AND DRUG ADMINISTRATION MANAGED RISK EVALUATION AND MITI-
GATION STRATEGY; (G) EMPTIED INJECTOR PRODUCTS OR EMPTIED MEDICAL
DEVICES AND THEIR COMPONENT PARTS OR ACCESSORIES; AND (H) DRUGS THAT ARE
USED SOLELY IN A CLINICAL SETTING.
3. "MANUFACTURER" MEANS A PERSON, COMPANY, CORPORATION OR OTHER ENTITY
ENGAGED IN THE MANUFACTURE OF COVERED DRUGS SOLD IN THE STATE. MANUFAC-
TURER DOES NOT INCLUDE A REPACKAGER OR WHOLESALER.
4. "PHARMACIES" MEANS ALL PHARMACIES REGISTERED UNDER SECTION
SIXTY-EIGHT HUNDRED EIGHT OF THE EDUCATION LAW THAT ARE PART OF A GROUP
OF TEN OR MORE ESTABLISHMENTS THAT CONDUCT BUSINESS UNDER THE SAME NAME,
OR OPERATE UNDER A COMMON OWNERSHIP OR MANAGEMENT, OR PURSUANT TO A
FRANCHISE AGREEMENT WITH THE SAME FRANCHISOR, AND ALL NONRESIDENT PHAR-
MACIES REGISTERED PURSUANT TO SECTION SIXTY-EIGHT HUNDRED EIGHT-B OF THE
EDUCATION LAW THAT PROVIDE COVERED DRUGS TO STATE RESIDENTS BY MAIL.
5. "DRUG TAKE BACK ORGANIZATION" MEANS AN ORGANIZATION DESIGNATED BY A
MANUFACTURER OR A GROUP OF MANUFACTURERS TO ACT AS AN AGENT ON BEHALF OF
THE MANUFACTURER OR GROUP OF MANUFACTURERS TO OPERATE AND IMPLEMENT A
DRUG TAKE BACK PROGRAM AS AUTHORIZED BY THIS ARTICLE.
6. "WHOLESALER" MEANS ANY PERSON, COMPANY, CORPORATION OR OTHER ENTITY
THAT SELLS OR DISTRIBUTES DRUGS AND COVERED DRUGS FOR RESALE TO AN ENTI-
TY IN THE STATE OTHER THAN A CONSUMER.
7. "REPACKAGER" MEANS AN ENTITY THAT OWNS OR OPERATES AN ESTABLISHMENT
THAT REPACKS AND RELABELS A PRODUCT OR PACKAGE CONTAINING A COVERED DRUG
FOR FURTHER SALE OR FOR DISTRIBUTION WITHOUT FURTHER TRANSACTION.
S 291. DRUG TAKE BACK. 1. ANY MANUFACTURER OF A COVERED DRUG SHALL:
(A) OPERATE A DRUG TAKE BACK PROGRAM APPROVED BY THE DEPARTMENT INDI-
VIDUALLY OR JOINTLY WITH OTHER MANUFACTURERS;
(B) ENTER INTO AN AGREEMENT WITH A DRUG TAKE BACK ORGANIZATION WHICH
SHALL OPERATE A DRUG TAKE BACK PROGRAM APPROVED BY THE DEPARTMENT; OR
(C) ENTER INTO AN AGREEMENT WITH THE DEPARTMENT TO OPERATE A DRUG TAKE
BACK PROGRAM ON ITS BEHALF.
2. ANY MANUFACTURER OF A COVERED DRUG, INDIVIDUALLY OR JOINTLY, OR A
DRUG TAKE BACK ORGANIZATION CONTRACTED BY A MANUFACTURER OF A COVERED
DRUG SHALL WITHIN ONE HUNDRED EIGHTY DAYS FROM THE EFFECTIVE DATE OF
THIS SECTION SUBMIT TO THE DEPARTMENT, IN A MANNER AND FORM DETERMINED
BY THE DEPARTMENT, A PROPOSED DRUG TAKE BACK PROGRAM THAT MEETS, AT A
MINIMUM, THE FOLLOWING REQUIREMENTS:
(A) CERTIFIES THE DRUG TAKE BACK PROGRAM WILL ACCEPT ALL COVERED DRUGS
REGARDLESS OF WHO PRODUCED THEM;
(B) PROVIDES CONTACT INFORMATION FOR THE PERSON SUBMITTING THE PLANNED
DRUG TAKE BACK PROGRAM WITH WHOM THE DEPARTMENT SHALL DIRECT ALL
INQUIRIES;
(C) DETAILS A COLLECTION SYSTEM TO PROVIDE CONVENIENT, ONGOING
COLLECTION SERVICES TO ALL PERSONS SEEKING TO DISPOSE OF COVERED DRUGS
PURSUANT TO SECTION TWO HUNDRED NINETY-TWO OF THIS ARTICLE THAT IS
S. 9100 3
GEOGRAPHICALLY DISTRIBUTED IN A WAY TO ENSURE ACCESS IN RURAL AND UNDER-
SERVED AREAS;
(D) DESCRIBES OTHER COLLECTION METHODS BY WHICH COVERED DRUGS WILL BE
COLLECTED BY AUTHORIZED COLLECTORS;
(E) EXPLAINS HOW COVERED DRUGS WILL BE SAFELY AND SECURELY TRACKED AND
HANDLED FROM COLLECTION THROUGH FINAL DISPOSAL AND DESTRUCTION, POLICIES
TO ENSURE SECURITY AND COMPLIANCE WITH ALL APPLICABLE LAWS AND REGU-
LATIONS INCLUDING DISPOSAL AND DESTRUCTION AT A PERMITTED WASTE DISPOSAL
FACILITY MEETING FEDERAL REQUIREMENTS;
(F) DESCRIBES THE PUBLIC EDUCATION AND OUTREACH ACTIVITIES THAT WILL
BE UNDERTAKEN WHICH SHALL INCLUDE ADVERTISING OF COLLECTION LOCATIONS ON
A WEBSITE AND THROUGH USE OF SIGNAGE AND OTHER WRITTEN MATERIALS, AND
HOW EFFECTIVENESS WILL BE EVALUATED;
(G) DETAILS HOW THE COSTS OF PHARMACY COLLECTION AND OTHER AUTHORIZED
COLLECTORS WILL BE REIMBURSED WHICH SHALL INCLUDE COSTS RETROACTIVE TO
THE EFFECTIVE DATE OF THIS ARTICLE, AND WHERE MORE THAN ONE MANUFACTURER
WILL BE INVOLVED IN THE PLANNED DRUG TAKE BACK PROGRAM, A PLAN FOR THE
FAIR AND REASONABLE MANNER OF ALLOCATED COSTS AMONG THE PARTICIPANTS IN
SUCH PROGRAM SUCH THAT THE COSTS PAID BY EACH MANUFACTURER IS REASONABLY
RELATED TO THE VOLUME OR VALUE OF COVERED DRUGS SOLD IN THE STATE; AND
(H) PROVIDES ANY FURTHER INFORMATION DEEMED APPROPRIATE BY THE DEPART-
MENT.
3. WITHIN THIRTY DAYS OF THE EFFECTIVE DATE OF THIS SECTION, EACH
WHOLESALER THAT SELLS COVERED DRUGS IN OR INTO THE STATE SHALL PROVIDE
THE DEPARTMENT WITH A LIST OF MANUFACTURERS THAT PRODUCE COVERED DRUGS.
THE DEPARTMENT MAY REQUEST UPDATED LISTS AT ITS DISCRETION.
4. A MANUFACTURER, INDIVIDUALLY OR JOINTLY, MUST PAY ALL ADMINISTRA-
TIVE AND OPERATIONAL FEES ASSOCIATED WITH THE DRUG TAKE BACK PROGRAM,
INCLUDING THE COST OF COLLECTING, TRANSPORTING AND DISPOSING OF COVERED
DRUGS FROM PHARMACIES AND OTHER AUTHORIZED COLLECTORS AND THE RECYCLING
OR DISPOSAL, OR BOTH, OF PACKING COLLECTED WITH THE COVERED DRUG.
MANUFACTURERS SHALL ALSO PAY COSTS INCURRED BY THE STATE IN THE ADMINIS-
TRATION AND ENFORCEMENT OF THE DRUG TAKE BACK PROGRAM. EXCLUSIVE OF
FINES AND PENALTIES, THE STATE SHALL ONLY RECOVER ITS ACTUAL COST OF
ADMINISTRATION AND ENFORCEMENT. IN INSTANCES WHERE MANUFACTURERS JOINTLY
CONDUCT A DRUG TAKE BACK PROGRAM, THE COSTS OF ADMINISTRATION AND
ENFORCEMENT SHALL BE FAIRLY AND REASONABLY ALLOCATED SUCH THAT THE
PORTION OF COSTS IS REASONABLY RELATED TO THE VOLUME OR VALUE OF COVERED
DRUGS THE MANUFACTURERS SELL IN THE STATE. NO MANUFACTURER MAY CHARGE A
POINT-OF-SALE OR OTHER FEE TO CONSUMERS, OR A FEE THAT COULD BE PASSED
ON TO CONSUMERS, TO RECOUP THE COST OF THEIR DRUG TAKE BACK PROGRAM.
5. WITHIN SIXTY DAYS OF RECEIPT OF A PROPOSED DRUG TAKE BACK PROGRAM,
THE DEPARTMENT, IN CONSULTATION WITH THE DEPARTMENT OF ENVIRONMENTAL
CONSERVATION, SHALL DETERMINE WHETHER SUCH PROPOSED DRUG TAKE BACK
PROGRAM COMPLIES WITH THE REQUIREMENTS OF THIS ARTICLE AND NOTIFY THE
APPLICANT. THE DEPARTMENT MAY CONDUCT A NOTICED PUBLIC HEARING PRIOR TO
APPROVAL. IF THE DRUG TAKE BACK PROGRAM IS APPROVED, THE DEPARTMENT
SHALL NOTIFY THE APPLICANT IN WRITING. IF THE DRUG TAKE BACK PROGRAM IS
NOT APPROVED, THE DEPARTMENT SHALL NOTIFY THE APPLICANT IN WRITING AND
THE APPLICANT SHALL SUBMIT A REVISED DRUG TAKE BACK PROGRAM PROPOSAL
WITHIN THIRTY DAYS. IF THE DEPARTMENT REJECTS THE SUBSEQUENT PROPOSAL,
THE MANUFACTURER OR MANUFACTURERS AT ISSUE SHALL BE OUT OF COMPLIANCE
WITH THIS ARTICLE AND SUBJECT TO THE ENFORCEMENT PROVISIONS PURSUANT TO
SECTION TWO HUNDRED NINETY-FOUR OF THIS ARTICLE. THE DEPARTMENT SHALL
PROVIDE, AND UPDATE ANNUALLY, ON ITS WEBSITE A LIST OF ALL MANUFACTURERS
PARTICIPATING IN A DRUG TAKE BACK PROGRAM APPROVED BY THE DEPARTMENT.
S. 9100 4
6. AT LEAST EVERY THREE YEARS, A MANUFACTURER, JOINTLY OR INDIVIDUAL-
LY, OR A DRUG TAKE BACK ORGANIZATION SHALL UPDATE ITS DRUG TAKE BACK
PROGRAM AND SUBMIT AN UPDATED PROPOSAL TO THE DEPARTMENT. A MANUFACTURER
WHO BEGINS TO OFFER A COVERED DRUG IN THE STATE AFTER THE EFFECTIVE DATE
OF THIS ARTICLE, SHALL PROVIDE EVIDENCE OF JOINING AN EXISTING APPROVED
DRUG TAKE BACK PROGRAM OR SUBMIT A PROPOSAL FOR A DRUG TAKE BACK PROGRAM
WITHIN NINETY DAYS FOLLOWING THE INITIAL OFFER FOR SALE OF A COVERED
DRUG. ANY PROPOSED CHANGE TO A DRUG TAKE BACK PROGRAM SHALL BE SUBMITTED
IN WRITING AND APPROVED BY THE DEPARTMENT PRIOR TO ANY CHANGE.
7. EACH APPROVED DRUG TAKE BACK PROGRAM SHALL REPORT TO THE DEPARTMENT
AT A DATE AND MANNER SET BY THE DEPARTMENT. THE DEPARTMENT SHALL SUBMIT
AN ANNUAL REPORT TO THE GOVERNOR, SPEAKER OF THE ASSEMBLY AND TEMPORARY
PRESIDENT OF THE SENATE BY JANUARY FIRST DETAILING ALL PROGRAM ACTIV-
ITIES, THE WEIGHT COLLECTED BY EACH PROGRAM, A DESCRIPTION OF COLLECTION
ACTIVITIES, THE NAME AND LOCATION OF ALL COLLECTION SITES, PUBLIC EDUCA-
TION AND OUTREACH ACTIVITIES, AN EVALUATION OF THE EFFICACY OF THE
PROGRAM AND EACH COLLECTION METHOD, AND ANY MANUFACTURER OUT OF COMPLI-
ANCE OR SUBJECT TO PENALTIES PURSUANT TO SECTION TWO HUNDRED NINETY-FOUR
OF THIS ARTICLE.
S 292. COLLECTION. 1. ALL PHARMACIES SHALL PROVIDE FOR THE SAFE
COLLECTION OF DRUGS, WHICH SHALL INCLUDE:
(A) OFFERING DRUG COLLECTION BY ONE OR MORE OF THE FOLLOWING METHODS:
(I) ON-SITE COLLECTION, DROPBOX, OR RECEPTACLE MEETING FEDERAL STAND-
ARDS;
(II) MAIL-BACK COLLECTION BY PREPAID ENVELOPES AS AUTHORIZED BY FEDER-
AL LAW AND REGULATION; OR
(III) OTHER FEDERAL DRUG ENFORCEMENT AGENCY APPROVED METHODS OF
COLLECTION.
(B) SIGNAGE PROMINENTLY DISPLAYED ADVERTISING SUCH DRUG COLLECTION TO
CONSUMERS.
2. ALL DRUG TAKE BACK PROGRAM OPERATORS SHALL NOTIFY OTHER POTENTIAL
AUTHORIZED COLLECTORS OF THE OPPORTUNITY TO SERVE AS AN AUTHORIZED
COLLECTOR FOR THE DRUG TAKE BACK PROGRAM. PARTICIPATION OF AUTHORIZED
COLLECTORS BESIDES PHARMACIES SHALL BE VOLUNTARY.
3. ALL COSTS OF PHARMACIES AND OTHER AUTHORIZED COLLECTORS SHALL BE
PAID OR REIMBURSED BY THE MANUFACTURER, JOINTLY OR INDIVIDUALLY, AS PART
OF THE DRUG TAKE BACK PROGRAMS REQUIRED BY THIS ARTICLE.
4. FOR ANY CITY WITH A POPULATION OF ONE HUNDRED TWENTY-FIVE THOUSAND
OR MORE AS OF THE LAST DECENNIAL CENSUS, THE COMMISSIONER SHALL ESTAB-
LISH BY REGULATION A DISTRIBUTION PLAN THAT ENSURES THAT ON-SITE
COLLECTION RECEPTACLE OR DROPBOX PLACEMENT SHALL BE REASONABLY ACCESSI-
BLE TO ALL RESIDENTS AND THAT PROVIDES FOR PROGRAM COST EFFICIENCY.
5. PHARMACIES PROVIDING FOR MAIL-BACK COLLECTION AS PART OF THE DRUG
TAKE BACK PROGRAM SHALL PROVIDE A VOUCHER FOR A PREPAID ENVELOPE UPON
DISPENSING A COVERED DRUG. SUCH VOUCHER SHALL INCLUDE INFORMATION ON
DRUG TAKE BACK AND SAFE DRUG DISPOSAL METHODS.
S 293. VIOLATIONS. VIOLATION OF THIS ARTICLE SHALL BE SUBJECT TO FINES
PURSUANT TO SECTION TWELVE OF THIS CHAPTER. EACH DAY IN WHICH THE
VIOLATION CONTINUES SHALL CONSTITUTE A SEPARATE VIOLATION.
S 294. JURISDICTION. JURISDICTION OF ALL MATTERS PERTAINING TO DRUG
DISPOSAL BY THIS ARTICLE IS VESTED EXCLUSIVELY IN THE STATE. ANY
PROVISION OF ANY LOCAL LAW OR ORDINANCE, OR ANY RULE OR REGULATION
PROMULGATED PRIOR TO, OR UPON THE EFFECTIVE DATE OF THIS SECTION, SHALL
BE PREEMPTED.
S 3. Section 3343-b of the public health law, as amended by chapter
379 of the laws of 2015, is amended to read as follows:
S. 9100 5
S 3343-b. Safe disposal of unused controlled substances. 1. The
department shall oversee a program for the safe disposal of unused
controlled substances by consumers in accordance with federal law AND
ARTICLE TWO-B OF THIS CHAPTER. Individual members of the public shall
be authorized to voluntarily surrender controlled substances listed on
schedule II, III, IV or V of section thirty-three hundred six of this
article in a secure manner, without identifying themselves. Safe
disposal methods shall be publicized consistent with the prescription
pain medication awareness program established pursuant to section thir-
ty-three hundred nine-a of this article AND ARTICLE TWO-B OF THIS CHAP-
TER.
2. The surrender of a controlled substance pursuant to this section
AND ARTICLE TWO-B OF THIS CHAPTER shall not constitute the possession,
transfer or sale of such controlled substance for purposes of this arti-
cle or the penal law.
3. [Disposal] EXCEPT AS PROVIDED IN ARTICLE TWO-B OF THIS CHAPTER,
DISPOSAL sites shall be operated by law enforcement agencies, pharmacies
and other Federal Drug Enforcement Administration authorized collectors
on a voluntary basis, PROVIDED, HOWEVER, THAT SUCH DISPOSAL SITES SHALL
NOT BE PRECLUDED FROM OPERATING AS PART OF A DRUG TAKE BACK PROGRAM
ESTABLISHED PURSUANT TO ARTICLE TWO-B OF THIS CHAPTER. Nothing in this
section shall require any political subdivision of the state to partic-
ipate in the program established in this section.
S 4. The department of health may adopt regulations as necessary to
implement and enforce the provisions of this title.
S 5. This act shall take effect on the one hundred eightieth day after
it shall have become a law. Effective immediately, the addition, amend-
ment and/or repeal of any rule or regulation necessary for the implemen-
tation of this act on its effective date are authorized to be made and
completed on or before such effective date.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.